JC
CELG

Jacobs & Co’s Celgene Corp CELG Stock Holding History

Jacobs & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-21,939
Closed -$2.18M – 136
2019
Q3 		$2.18M Sell
21,939
-706
-3% -$67.1K 0.35% 76
2019
Q2 		$2.09M Sell
22,645
-4,575
-17% -$434K 0.34% 79
2019
Q1 		$2.57M Sell
27,220
-9,489
-26% -$830K 0.44% 72
2018
Q4 		$2.35M Sell
36,709
-1,472
-4% -$109K 0.46% 71
2018
Q3 		$3.42M Buy
38,181
+3,277
+9% +$290K 0.58% 62
2018
Q2 		$2.77M Buy
34,904
+158
+0.5% +$13.1K 0.5% 72
2018
Q1 		$3.1M Buy
34,746
+5,237
+18% +$503K 0.57% 66
2017
Q4 		$3.04M Buy
29,509
+2,925
+11% +$330K 0.55% 68
2017
Q3 		$3.88M Buy
26,584
+1,210
+5% +$165K 0.73% 58
2017
Q2 		$3.29M Buy
25,374
+705
+3% +$86.4K 0.65% 63
2017
Q1 		$3.07M Buy
24,669
+4,395
+22% +$526K 0.63% 68
2016
Q4 		$2.35M Buy
20,274
+666
+3% +$74.2K 0.51% 74
2016
Q3 		$2.05M Buy
19,608
+1,161
+6% +$126K 0.46% 76
2016
Q2 		$1.82M Buy
18,447
+925
+5% +$95.7K 0.43% 76
2016
Q1 		$1.75M Sell
17,522
-65
-0.4% -$6.69K 0.42% 75
2015
Q4 		$1.88M Buy
17,587
+680
+4% +$78.7K 0.49% 72
2015
Q3 		$1.83M Sell
16,907
-38
-0.2% -$4.72K 0.49% 75
2015
Q2 		$1.96M Sell
16,945
-50
-0.3% -$5.72K 0.49% 73
2015
Q1 		$1.96M Sell
16,995
-145
-0.8% -$17.3K 0.5% 74
2014
Q4 		$1.92M Buy
17,140
+1,248
+8% +$132K 0.5% 74
2014
Q3 		$1.51M Hold
15,892
– – 0.43% 76
2014
Q2 		$1.36M Buy
+15,892
New +$1.21M 0.4% 75

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Jacobs & Co's CELG Position: Q4 2019 in Review

Jacobs & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 21,939 shares — an estimated $2.18M sold.

Jacobs & Co first reported a position in CELG in Q2 2014 and held it in 22 quarters. The position peaked at $3.88M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Jacobs & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Jacobs & Co sold 21,939 Celgene Corp shares in Q4 2019, an estimated $2.18M.
  • Jacobs & Co first reported a position in Celgene Corp in Q2 2014 and held it in 22 quarters.
  • Jacobs & Co's Celgene Corp position peaked at $3.88M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Jacobs & Co's 13F filing for Q4 2019, filed 29 Jan 2020.